Stay updated on Ramucirumab Plus Nivolumab in Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Ramucirumab Plus Nivolumab in Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ramucirumab Plus Nivolumab in Gastric Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    Revision: v3.3.3 added; HHS Vulnerability Disclosure and Revision: v3.3.2 removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T08:48:58.000Z thumbnail image
  3. Check
    14 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2; no visible changes to study details or layout.
    Difference
    0.1%
    Check dated 2025-12-01T15:49:33.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.1 on the page; core study content and details remain unchanged.
    Difference
    0.1%
    Check dated 2025-11-24T11:34:12.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    The government funding/operating status notice was removed from the page. The rest of the study details and page content remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T06:16:01.000Z thumbnail image
  8. Check
    58 days ago
    Change Detected
    Summary
    The updates appear to be cosmetic adjustments to the page header and layout, with no changes to core study information. There are no changes to eligibility criteria, interventions, or primary/secondary outcomes or dates. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T00:48:06.000Z thumbnail image
  9. Check
    86 days ago
    Change Detected
    Summary
    Summary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.
    Difference
    5%
    Check dated 2025-10-05T06:52:51.000Z thumbnail image

Stay in the know with updates to Ramucirumab Plus Nivolumab in Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ramucirumab Plus Nivolumab in Gastric Cancer Clinical Trial page.